Actively Recruiting
Belgian Central Sleep Apnea Registry (B-CARE)
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-03
1500
Participants Needed
14
Research Sites
N/A
Total Duration
On this page
Sponsors
U
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
P
Philips Respironics
Collaborating Sponsor
AI-Summary
What this Trial Is About
Central sleep apnea (CSA) involves periods during sleep when breathing temporarily stops or decreases due to a lack of effort to breathe. This condition can cause excessive daytime sleepiness and poor sleep quality and is linked to higher mortality in patients with heart failure. Researchers are studying the factors that influence treatment choices and how well patients follow these treatments for CSA in Belgium, as well as the effects of these treatments. Participants in this study will receive routine care as part of a registry, without additional interventions from the study. Eligible participants have a confirmed diagnosis of CSA based on specific breathing event measurements from sleep studies. This observational study will follow patients over five years to monitor their treatment decisions, compliance with treatments, and health outcomes. Throughout the study, participants' treatment choices and compliance will be tracked along with assessments of their health-related quality of life and sleep quality using surveys like the Short Form 36 Health Survey and Pittsburgh Sleep Quality Index. Researchers will also monitor mortality over the five-year period. The study involves regular evaluations but no experimental treatments, focusing on real-world data collection to better understand CSA management.
CONDITIONS
Brief Title
Belgian Central Sleep Apnea REgistry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Apnea/hypopnea index of 15 or more per hour of sleep with more than 50% non-obstructive events as shown by polysomnography
- Able and willing to provide written informed consent
You will not qualify if you...
- Mental disability preventing understanding of the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 5 years
Participants who undergo routine care are observed to evaluate treatment choices, compliance, and health outcomes over time.
Periodic visits over 5 years
Trial Site Locations
Total: 14 locations
1
OLV Ziekenhuis
Aalst, Belgium, 9300
Actively Recruiting
2
ZNA Middelheim
Antwerp, Belgium, 2020
Actively Recruiting
3
UZA
Antwerp, Belgium, 2650
Actively Recruiting
4
AZ Sint-Jan
Bruges, Belgium, 8000
Actively Recruiting
5
CHU Saint-Pierre
Brussels, Belgium, 1000
Actively Recruiting
6
Ghent University Hospital
Ghent, Belgium, 9000
Actively Recruiting
7
Jessa Ziekenhuis
Hasselt, Belgium, 3500
Actively Recruiting
8
AZ Groeninge
Kortrijk, Belgium, 8500
Actively Recruiting
9
CH Jolimont
La Louvière, Belgium, 7100
Actively Recruiting
10
UZ Leuven
Leuven, Belgium, 3000
Actively Recruiting
11
CHR de la Citadelle
Liège, Belgium, 4000
Actively Recruiting
12
CHU UCL Namur
Namur, Belgium, 5530
Actively Recruiting
13
AZ Glorieux
Ronse, Belgium, 9600
Actively Recruiting
14
AZ Turnhout
Turnhout, Belgium, 2300
Actively Recruiting
Research Team
D
Dries Testelmans, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here